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Abstract 
 Background: Conflicting evidence exists in respect of gender 
differences in outcomes after Acute Coronary Syndromes (ACS). 
Aim: Evaluation of gender differences in outcomes after ST – elevation 
Acute Myocardial Infarction (STEMI) in different age groups of patients 
following percutaneous coronary interventions (PCI). 
Methods:   We studied consecutive 292 female and consecutive 311 male 
STEMI patients who underwent PCI with stent implantation.  Study 
individuals were divided into groups by the gender and age (<65, 65-75, >75 
years). Patients with total ischemic time >4 hours were excluded from the 
study.  In hospital, 45-day and one year outcomes (death from cardiovascular 
causes, repeated angiography and revascularization) were evaluated, as well 
as several factors which may influence disease outcomes.  
Results:  Total death rate in hospital, during 45-days and one year period: in 
women - 0.168, 0.250, 0.438, in men - 0.161, 0.289, 0.408, differences were 
not significant (p> 0.05). In hospital death rate in study groups (age groups 
<65, 65-75,>75years): in women -0.112, 0.155, 0.257, in men -0.121, 0.176, 
0.216. Forty five-day mortality rate in study groups: in women -0.135, 0.279, 
0.338, in men- 0.226, 0.279, 0.471; one year mortality rate in study groups: 
in women -0.315, 0.419, 0.622, in men - 0.347, 0.419, 0.529. Differences are 
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statistically significant in age group under 65 years (P<0.05).  Age under 65 
years is associated with lower probability of in hospital and 45 days 
mortality (OR -0.53, 95% CI 0.9 – 0.25, OR- 0.36, 95% CI 0.18-0.72) in 
females, as well as with one year mortality in females OR- 0.47 , 95%CI 
0.28 -0.80 and 45 days mortality in males OR-0.35, 95%CI 0.59-0.99. Study 
showed significantly (P<0.005)  higher rate of  repeated angiography (0.154 
vs 0.077) and revascularization (0.127 vs 0.026) in females as compared with 
men after STEMI following primary PCI with stent implantation,  
Conclusions: a) Mortality rates (in hospital, 45 days and one year) after 
STEMI in patients with ischemic time <4 hours who underwent PCI with 
stent implantation did not differ between genders; b) Women younger 65 
years with STEMI after timely revascularization have better prognosis as 
compared with their male counterparts and females of other groups; c) Risk 
of one year repeated angiography and revascularization in one year is higher 
in female patients with STEMI following primary PCI with stent 
implantation. 
 
Keywords: Gender Differences, ST – elevation Acute Myocardial Infarction 
(STEMI), percutaneous coronary interventions (PCI) 
 
Introduction 
 Most of earlier studies suggested that female gender is associated 
with worse prognosis after acute coronary syndromes (ACS) (Greenland 
P, Reicher-Reiss H, Goldbourt U, et.al., 1991), (Cowley M., Mullin S., 
Kelsey S. et al., 1985). However, prognosis of AMI improved during the last 
decades as a result of implementation of innovative treatment strategies 
(Duvernoy CS, Smith DE, Manohar P, et.al., 2010), (Park JS, Kim YJ, Shin 
DG, et.al. , 2010), (Singh M, Rihal CS, Gersh BJ, et al., 2008), (Lansky AJ, 
Hochman JS, Ward PA, et al., 2005). Some studies showed the similar 
success rate of primary Percutaneous Coronary Intervention (PCI) and in-
hospital outcomes in both genders (Singh M, Rihal CS, Gersh BJ, et al., 
2008), (Liu Y, Wang LF, Yang XF, et.al., 2008), (Radovanovic D, Erne P, 
Urban P, et.al., 2007), while others did not (Mehilli J, Kastrati A, 
Dirschinger J, et. al., 2002), (Jacobs A.K., Johnstone J.M., Haviland A. et al., 
2002). Significantly higher unadjusted mortality rate was observed in women 
(Thompson CA, Kaplan AV, Friedman BJ, et. al. , 2006) - a higher short-
term mortality in females with STEMI (Park JS, Kim YJ, Shin DG, et.al., 
2010), (Rasoul S, Ottervanger JP, de Boer MJ, et.al., 2009), (Benamer H, 
Tafflet M, Bataille S, et al., 2011) and female patients with acute STEMI still 
have a worse prognosis during the long-term follow-up (Liu Y, Wang LF, 
Yang XF, et.al., 2008), (Wijnbergen I, Tijssen J, van 't Veer M, et.al., 2013), 
but after adjustment for age and cardiovascular risk factors, the long-term 
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mortality rate in patients with STEMI did not differ between genders (Singh 
M, Rihal CS, Gersh BJ, et al., 2008), (Jacobs A.K., Johnstone J.M., Haviland 
A. et al., 2002), (Thompson CA, Kaplan AV, Friedman BJ, et. al., 2006), or 
was lower in women (Lee KH, Jeong MH, Ahn YK, et. al., 2008), (De Luca 
G, Gibson CM, Gyöngyösi M.et.al., 2010), (Bhan V, Cantor WJ, Yan 
RT, et.al., 2012).   
     Age was an important determinant for clinical outcomes in the group of 
consecutive STEMI patients transferred for primary PCI (Dziewierz A. 
Zbigniew Siudak Z. Rakowski T.et.al., 2012).  Age-adjusted hospital 
mortality was higher in women and was associated with a lower rate of 
percutaneous coronary intervention (Milcent C, Dormont B, Durand-Zaleski 
I, et.al., 2007). Whether female gender can be considered as an independent 
risk factor remains unclear. Older age of women with ACS at presentation is 
main confounding factor (Rasoul S,Ottervanger JP, de Boer MJ, et.al., 2009), 
(Berger JS, Brown DL., 2006). Women were underrepresented in most of 
studies and comparison between genders was difficult due to differences in 
age between male and female subjects. It is important to clarify possible 
differences between men and women in a large prospective cohort study, 
with equal numbers of male and female patients. Furthermore, as age is an 
important confounding factor, men and women of similar age should be 
compared (Berger JS, Brown DL., 2006).  
    The aim of the study was to evaluate gender differences in outcomes after 
ST – elevation Acute Myocardial infarction (STEMI) in different age groups 
of patients following percutaneous coronary interventions (PCI).  
 
Patients and methods 
     Consecutive 292 female and   consecutive 311 male STEMI patients (total 
number - 603) admitted to the hospital during 2009-2010 and underwent PCI 
with stent implantation were studied. In vast majority of the patients bare 
metal stents were used. Study individuals  were divided into groups by the 
gender and age: males – I group , females – II group,   Ia group -124 (males 
< 65 years),  Ib group -136 (males 65 – 75 years) , Ic group -51 (males >75 
years),  IIa group - 89 (females  < 65 years ),  IIb   group -129 (females  65 – 
75 years),  IIc   group -74 (females >75 years ). Patients with total ischemic 
time (defined as time from symptom onset to first coronary intervention) >4 
hours were excluded from the study. In hospital, 45-day and one year 
outcomes were evaluated, as well as several factors (co-morbidities, the 
initial level of Troponin I - 6 hours later the symptom onset, EF %- 
examined by echocardiography) which may influence disease outcomes in 
all groups of patients . All patients were linked to the one year follow up, and 
follow up was performed by outpatient visits or telephone call. 
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    The study was carried out according to the principles of the Declaration of 
Helsinki and approved by the local Ethics Committee. Written informed 
consent was obtained from all patients.  
 
STEMI definition 
    STEMI was defined by symptoms, electrocardiographic changes - ST-
segment elevation and/or a new development of LBBB at presentation, 
cardiac marker elevation (troponin I above individual hospital cut-off levels 
for MI). 
 
Study endpoints 
     The primary endpoint was   death from cardiovascular causes. Secondary 
endpoints included repeated angiography and revascularization (PCI or 
CABG).  
 
Statistics  
    Continuous variables are expressed as mean ± SD, and categorical 
variables as frequencies. Continuous variables were compared with the use 
of the students’t test and categorical variables with the use of the Fisher's 
Exact Test.  All statistical tests were two-tailed, and a p value < 0.05 was 
considered as statistically significant. The odds ratio (OR) and 95% 
confidence intervals (95% CI) were calculated. All statistical analyses were 
performed using SPSS version 17.0.  
 
Results  
    Prevalence of diabetes, CKD and COPD in all study population did not 
differ significantly between genders (Table1). Prevalence of hypertension 
was significantly higher in women. Prevalence of diabetes, hypertension and 
CKD increases with age. Comparison of different age groups showed higher 
prevalence of diabetes, hypertension and lower prevalence of CKD in males 
<65 years as compared with age matched females (Table 2). Prevalence of 
Diabetes and Hypertension was higher in females of 65-75 years than in the 
same age group of males (Table 2). 
    Mean EF% in males (47.65+11.136) was higher as compared with females 
(44.63+12.441) (p<0.01). No difference in mean initial troponin I level 
between genders was revealed (mean level in males – (0.311 ng/ml+0.195, in 
females - 0.332 ng/ml+0.211, P>0.05). 
    No differences in overall mortality rates between genders were found 
(Table1). In hospital, 45-day and one year mortality increases with age.  In 
age group <65 mortality was lower in females as compared with males. 
Mortality rates did not differ between genders in age groups 65-75 (Table2).  
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Table 1 Mortality and co-morbidities in female and male patients with STEMI 
C
o 
- m
or
bi
di
tie
s Variables                           Males                               Females                        P 
                                        n=311(grII)                         n=292 (grI) 
                                         Abs (freq)                         Abs (freq) 
Diabetes                          124 (0.40)                          123 (0.42)                    0.5775 
hypertension                   195 (0.63)                          219 (0.75)                    0.0011 
CKD                                46   (0.15)                           58  (0.20)                    0.0998 
COPD                              63   (0.20)                          44   (0.15)                    0.0959 
m
or
ta
lit
y 
 
In-hospital mortality       50 (0.161)                          49 (0.168)                    0.8158 
45-day mortality             90 (0.289)                          73 (0.250)                    0.2768 
1-year mortality              127(0.408)                         128(0.438)                   0.4566 
 
*Table 2 Co -morbidities and mortality in different age groups of patients with STEMI 
C
o-
m
or
bi
di
tie
s 
Variables 
 
 
 
Diabetes 
Hypertensio
n 
CKD 
COPD 
       Females                                        Males 
      I   n=292                                     II    n=311 
 IIa (n=89)   IIb (n=129)  IIc ( n=74)     Ia (n=124)   Ib  n=136)   Ic  (n=51) 
Abs.(freq)     Abs.(freq)     Abs.(freq)     Abs.(freq)    Abs.(freq)  Abs.(freq) 
26  (0.29)     60 (0.46)        37(0.50)       39 (0.31)      59 (0.43)     25 (0.49)  
53  (0.59)    106(0.82)        60 (0.81)      76 (0.61)      74 (0.54)     45 ( 0.88) 
11 (0.12)     21(0.16)          26 (0.35)      13 (0.10)      18 (0.13)     15 (0.29) 
11 (0.12)     18(0.14)          15 (0.29)      24 (0.19)      24 (0.17)     15 (0.29) 
 
10 (0.12)     20 (0.15)         19 (0.25)      15 (0.12 )      24 (0.17)    11 (0.29) 
12 (0.11)     36 (0.27)         25 (0.33)      28 (0.26)     38 (0.27)      24 (0.47) 
28 (0.13)     54 (0.41)         46 (0.62)      43 (0.34)     57 (0.41)     27 (0.52) 
 
M
or
ta
lit
y 
 
In-hospital 
45 -day 
One-year 
 
* p values for data demonstrated in table 2 are given in table 3 
 
Table 3 P values for table 2 
groups                                                    P value 
 
 
IIa –Ia 
IIb- Ib 
IIc -Ic 
IIa-IIb 
IIa-IIc 
IIb-IIc 
Ia-Ib 
Ia-Ic 
Ib-Ic 
                   Co-morbidities                                    Mortality 
Diabetes   hypertension  CKD     COPD        In-hospital       45-day       one-year 
0.0068          0.0031         0.0006   0.1710           0.0167            0.0021         0.0001 
0.0143          0.0002         0.1775   0.2493           0.4336            0.3309         0.2410 
0.9145          0.2855         0.5047   0.2414           0.5987            0.1367         0.3059 
0.0104          0.0002         0.4226   0.7340           0.3697            0.0117         0.1201 
0.0068          0.0031         0.0006   0.1710           0.0167            0.0021         0.0001 
0.6329          0.8469         0.0022    0.7235           0.0774           0.3806         0.0055 
0.0478          0.0005         0.4949    0.1475           0.2115           0.3221         0.2320 
0.0288         0.0000          0.0020    0.0786           0.1104           0.0013         0.0254 
0.4912         0.0012          0.0100    0.0958           0.5414           0.0136         0.1780 
 
 Diabetes, hypertension, CKD and age >75 increases risk of mortality 
in females (RR-         1.89,95% CI  1.48 -  2.43, RR- 1.39, 95% CI 1.27 -  
1.52, RR-4.03, 95% CI 2.66 – 6.11                RR-2.60, 95% CI  1.34- 5.03 ) . 
Risk of mortality in males is higher in individuals with Hypertension, 
Diabetes, COPD and CKD (RR 1.70 , 95% CI 1.51- 1.92,RR 2.61, 95% CI 
2.09 - 3.26 , RR2.25, 95% CI 1.44- 3.52,  RR 6.21  ,95% CI 3.79- 10.19) . 
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 Diabetes, hypertension, CKD and age >75 increases in hospital 
mortality in females ( OR-3.92(95%CI:2.02-7.60), OR-20.21(2.74-14924), 
OR-7.45(3.80-14.64), OR-4.14(1.13-2.16).,                In hospital mortality in 
males rises with  Hypertension - OR=18.61(4.43-78.2), Diabetes – 
OR=9.4(4.62-21.42), COPD - OR=3.02(1.57(-5.83) and CKD - 
OR=11.43(5.61-23.28). Age < 65 found to be predictor of favorable 
prognosis in females. Age under 65 years was associated with lower 
probability of in hospital and 45 days mortality (OR -0.53, 95% CI 0.9 – 
0.25), OR- 0.36, 95%CI (0.18-0.72) , as well as one year mortality in 
Females (Figure 1).  
 Age < 65 is associated with lower 45-day mortality in males (OR -
0.35(0.59-0.99). Diabetes, hypertension, CKD and age >75 increases 45-day 
mortality in females (OR-4.00 95% CI 2.28-7.02, OR-7.94 95%CI 2.78-
22.62, OR-9.69 95%CI 5.10-18.43, OR-1.8195%CI 1.01-3.22) as well as in 
males(OR-5.39 95%CI 3.17-9.17, OR-17.16 95%CI 6.70-17.16, OR-14.07 
95% CI 6.57-30.13 and  OR-2.61 95%CI 1.41-4.84).  COPD, also, is a 
predictor of adverse outcome in males (OR-4.39 95%CI 2.46-7.84). 
 Hypertension, Diabetes, CKD, COPD and age above 75 are 
associated with higher one-year mortality in both genders (Figure 1).  
Figure 1 One-year mortality (Odds Ratio) in different groups of patients with STEMI 
 
 
Repeated angiography and revascularization rates during one year 
after primary PCI were higher in women (Table 4). Repeated angiography 
and revascularization rates during one year after primary PCI were 
significantly higher in women >75 years as compared with age matched man 
(Table 4). Female gender increases chance of   one-year Repeated 
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Angiography and revascularization in patients aged >75 (OR - 4.29, 95% CI 
1.70 -17.63).  
Table 4 Repeated Angiography and Revascularization in different age groups of 
females and males with STEMI 
 
 
 
 
 
 
 
 
In- 
Hospital 
 
 
45 days 
 
 
 
One year 
                      
                   Repeated  Angiography                               Repeated  revascularization 
                 Females                  Males               P               Females                  Males                P 
             Abs,(freq,)                 Abs,(freq,)                        Abs,(freq,)                 Abs,(freq,) 
Age 
<65        1 (0.011)               3 (0.024)          0.8625         1 (0.011)                  3 (0.024)            0.8625 
65 -75    5 (0.039)               6 (0.044)          0.9203        4  (0.031)                 2 (0.015)            0.6172 
>75        8 (0.108)              2 (0.039)           0.2943        5 (0.068)                  1 (0.020              0.4101 
Total    14 (0.048)              11(0.035)          0.5839       10 (0.034)                6 (0.019)             0.3712 
<65       1 (0.011)               3 (0.024)           0.8625        1 (0.011)                  2 (0.016)             0.7773 
65 -75   7 (0.054)               7 (0.051)           0.8625        5 (0.039)                  3 (0.022)             0.6548 
>75      10 (0.135)              2 (0.039)           0.1380        5 (0.068)                  1 (0.020)             0.2059 
Total    18 (0.062)              12( 0.039)        0.2733        11 (0.031)                 6 (0.019)             0.5270 
<65       6 (0.067)               7  (0.056)          0.9203        1  (0.011)                  5 (0.040)            0.4020 
65 -75    9 (0.070)              10 (0.074)         0.9203        7 (0.054)                   2 (0.015)            0.1516 
>75       30 (0.405)             7 (0.137)           0.0027        29 (0.392)                1 (0.020)             0.0000 
Total     45 (0.154)            14 (0.077)          0.0043        37 (0.127)                8 (0.026)             0.0000                 
 
 
Discussion:  
    Inconsistence of data regarding gender differences in outcomes of ACS 
may be explained by heterogeneity of population included in different 
studies: in some of them patients with STEMI were included, while in other 
studies patients with non-STEMI and unstable angina were also involved. 
Large variation in mean age of study groups makes difficult to compare 
results of different studies. In most of studies women are underestimated. By 
the existed data in several studies the total ischemic time was longer in 
women (Lee KH, Jeong MH, Ahn YK, et. al., 2008), (De Luca G, Gibson 
CM, Gyöngyösi M.et.al., 2010), (Lee CY, Hairi NN, Wan Ahmad WA, 
et.al., 2013). It should be considered that the outcomes may be greatly 
influenced by the prolongation of ischemic time. To resolve the question 
whether female gender is an independent risk factor causing worse outcomes 
in ACS, similar number of patients of different genders with similar 
characteristics should be compared. In our study relatively homogeneous 
groups of patients of both genders were investigated (individuals with 
STEMI and total ischemic time <4 hours, data in the same age groups of 
patients were compared, all study subjects underwent PCI with stent 
implantation). Previous studies reported that women younger than 65 years 
have worse prognosis as compared with men of the same age group (Berger 
JS, Brown DL., 2006) (Regitz-Zagrosek V., Lehmkuhl E., Hocher B. et al., 
2004).  It may be caused by high cardiovascular risk burden, as well as 
delayed hospitalization and less aggressive treatment. According to the data 
of our research, women under 65 years have better prognosis (in-hospital, 45 
days and one year) as compared with their male counterparts. It should be 
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noted that they were hospitalized within 4 hours from symptom onset, as 
well as men enrolled in research and received the same treatment as men of 
similar age group. Hypertension and diabetes were observed in female 
patients more frequently than in male counterparts (Greenland P, Reicher-
Reiss H, Goldbourt U, et.al., 1991), (Singh M, Rihal CS, Gersh BJ, et al., 
2008), (Thompson CA, Kaplan AV, Friedman BJ, et. al., 2006). Women 
were significantly older and had significantly higher rates of diabetes 
mellitus, hypertension, chronic renal failure (Lee CY, Hairi NN, Wan 
Ahmad WA, et.al., 2013), (Dey S, Flather MD, Devlin G, et al., 2009).  
According to the data of our research, rate of hypertension was significantly 
higher in women, but frequency of diabetes, renal failure and COPD did not 
differ significantly between genders. Nevertheless, comparison of different 
age groups  shoed lower prevalence of co-morbidities in women <65 years 
and in contrast of it, higher prevalence of concomitant diseases in females  
65-75 years as compared with age matched males. No differences in 
prevalence of co-morbidities between genders above 75 years were revealed. 
Co-existence of diabetes, hypertension and CKD worsens prognosis after 
STEMI in both genders. 
     The higher in-hospital mortality noted in women is likely multifactorial 
and may be largely due to increased risk profile (advanced age at PCI, more 
frequent presentation with acute coronary syndrome, and higher prevalence 
of co -morbid conditions) (Singh M, Rihal CS, Gersh BJ, et al., 2008). 
Differences in mortality between men and women with STEMI treated with 
PCI were shown to be age- depended (Otten AM, Maas AH, Ottervanger 
JP, et.al., 2013), (Presbitero P, Carcagnì A.et.al., 2003). According to our 
results, overall, in hospital mortality did not differ significantly between 
genders and one year mortality is lower in women aged <65 as compared 
with men of the same age group. Higher mortality in males <65 may be due 
to higher prevalence of co - morbidities as compared with age matched 
females. Risk of mortality (in hospital, 45 day and one-year) in females 
increases above the age of 75 years. No differences in mortality rates 
between genders in age groups 65-75 were noted. Mortality rates did not 
differ significantly in males and females above 75 years. 
    By our results female gender is associated with higher rate of both early 
and later repeated angiography and revascularization after STEMI. Further 
research (large scale randomized control trials) is needed to confirm this 
finding and identify possible reasons for it. 
 
Conclusion 
 a) Mortality rates (in-hospital, 45 days and one year) after STEMI in 
patients with ischemic time <4 hours who underwent PCI with stent 
implantation did not differ between genders;   b) Women younger 65 years 
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with STEMI after timely revascularization have better prognosis as 
compared with their male counterparts and females of the other groups; c) 
Risk of  repeated angiography and revascularization after one year are higher 
in female patients with STEMI following primary PCI with stent 
implantation. 
 
Study limitations 
 Retrospective design, single centre study with limited size of 
included population; Possible influence of selection bias; Data missing 
regarding coronary anatomy and severity of lesions, amount of implanted 
stents, location of infarct , KILLIP class of heart failure, severe arrhythmias, 
drug treatment regimen during one year period– factors may influence 
outcomes. We have no data regarding sex differences in STEMI patients 
with delayed hospitalization and their outcomes, as well as, generally, 
differences of outcomes in patients treated conservatively.  
 Further research is needed to define issues regarding sex-specificity 
features of disease course, treatment efficacy and outcomes in patients with 
STEMI. 
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